 |
|
|
|
|
Indiana Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing IndianaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Acura Pharmaceuticals, Inc.
| | | | | Phone: | (574) 842-3305 | | Fax: | (574) 842-2519 | | Year Established: | 1935 | | Ticker: | ACUR | | Exchange: | NASDAQ | | Main Contact: | James Emigh, R.PH., MBA, VP, Corporate Development | | | | Other Contacts: | Gregory A. Spinner, Director of Logistics and Special Projects
Ronald L. Leech, Senior Director Quality & Analytical Chemistry
Peter A. Clemens, CPA, Senior VP & CFO
Robert A. Seiser, CPA, VP, Treasurer & Corporate Controller
Albert W. Brzeczko, Ph.D., VP, Technical Affairs
John G. Gilkay, P.E., Director of EHS & Engineering
Robert B. Jones, President & CEO
| | | | Company Description | | Acura Pharmaceuticals (formerly Halsey Pharmaceuticals) is a specialty pharmaceutical company developing and commercializing tamper-resistant products to combat medication abuse and misuse. The Centers for Disease Control and Prevention estimates that one person dies every 19 minutes from prescription drug abuse in the United States. For nearly a decade, Acura has been on the forefront of developing solutions to combat this epidemic, with products utilizing the Company’s proprietary abuse deterrent AVERSION® and IMPEDE® Technologies. | |
|
|
|
|
|
|
|
